EUVIMEDEUVIMED entdecken
Editorial

From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles

M Vijayasimha, M Srikanth, S Hari Priya

Medicinal Chemistry Research · 2026-06 · 35 (6) · 1003-1004

DOI: 10.1007/s00044-026-03574-x ↗

Kurz gefasst

Editorial in der Zeitschrift Medicinal Chemistry Research, online erschienen am 18.05.2026. Verfasst von M Vijayasimha und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Allied Health Science, Chandigarh University, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University Institute of Allied Health Science, Chandigarh University, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in.
  • Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Medical Rd, Rohtak, 124001, Haryana, India.
  • School of Allied Health Sciences, Department of Biochemistry, Malla Reddy University, Hyderabad, India.

Zitieren

APA

Vijayasimha, M., Srikanth, M., & Priya, S. H. (2026). From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles. Medicinal Chemistry Research, 35(6), 1003-1004. https://doi.org/10.1007/s00044-026-03574-x

Vancouver

Vijayasimha M, Srikanth M, Priya SH. From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles. Medicinal Chemistry Research. 2026;35(6):1003-1004. doi:10.1007/s00044-026-03574-x

BibTeX
@article{Vijayasimha2026,
  author = {Vijayasimha, M and Srikanth, M and Priya, S Hari},
  title = {From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  volume = {35},
  number = {6},
  pages = {1003--1004},
  doi = {10.1007/s00044-026-03574-x}
}
Kostenlos starten →